Literature DB >> 19944259

Von Willebrand disease in women: awareness and diagnosis.

Andra H James1.   

Abstract

Based on its pattern of inheritance, von Willebrand disease (VWD) is expected to affect an equal number of men and women. Clinically, however, more women are diagnosed with VWD than men because the bleeding symptoms associated with VWD are more readily apparent during menstruation and childbirth. Menorrhagia is one of the most common symptoms of VWD, and the prevalence of VWD is increased in women who present with menorrhagia. Other obstetric/gynaecological symptoms of VWD include haemorrhagic ovarian cysts, endometriosis, and postpartum haemorrhage. Awareness of VWD as a possible cause of menorrhagia is low among clinicians, including obstetricians and gynaecologists. Simple screening techniques can identify women who may have an underlying bleeding disorder. Several medical and surgical treatment options are available for menorrhagia, and the appropriate choice of therapy can be tailored to the individual needs of the patient. Adequate prophylaxis during surgery and childbirth may help to prevent bleeding complications in women with VWD.

Entities:  

Mesh:

Year:  2009        PMID: 19944259     DOI: 10.1016/S0049-3848(09)70151-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Authors:  Igor Govorov; Lena Ekelund; Roza Chaireti; Petra Elfvinge; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

2.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

3.  Achieving hemostasis in dermatology - Part 1: Preoperative, intraoperative, and postoperative management.

Authors:  Ravneet Ruby Kaur; Jaimie B Glick; Daniel Siegel
Journal:  Indian Dermatol Online J       Date:  2013-04

4.  Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.

Authors:  Igor Govorov; Signe Löfgren; Roza Chaireti; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

Review 5.  The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review.

Authors:  Marieke C Punt; Tanja H Aalders; Kitty W M Bloemenkamp; Mariette H E Driessens; Kathelijn Fischer; Marlies H Schrijvers; Karin P M van Galen
Journal:  J Thromb Haemost       Date:  2020-05-12       Impact factor: 5.824

6.  Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.

Authors:  Igor Govorov; Katarina Bremme; Tomas L Lindahl; Margareta Holmström; Eduard Komlichenko; Roza Chaireti; Miriam Mints
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

7.  Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders.

Authors:  Sumedha Arya; Pamela Wilton; David Page; Laurence Boma-Fischer; Georgina Floros; Katie N Dainty; Rochelle Winikoff; Michelle Sholzberg
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

8.  Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims.

Authors:  Robert F Sidonio; Ayesha Zia; Dana Fallaize
Journal:  J Blood Med       Date:  2020-01-06

9.  The Cost of Von Willebrand Disease in Europe: The CVESS Study.

Authors:  George Morgan; Sarah Brighton; Mike Laffan; Jenny Goudemand; Bethany Franks; Alan Finnegan
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

10.  Antigenic Peptides Capable of Inducing Specific Antibodies for Detection of the Major Alterations Found in Type 2B Von Willebrand Disease.

Authors:  Marina de Oliveira Paro; Cyntia Silva Ferreira; Fernanda Silva Vieira; Marcos Aurélio de Santana; William Castro-Borges; Maria Sueli Silva Namen-Lopes; Sophie Yvette Leclercq; Cibele Velloso-Rodrigues; Milton Hércules Guerra de Andrade
Journal:  Int J Pept       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.